FDA Inspection 1290840 — Transpire Bio Inc
The FDA completed an inspection of Transpire Bio Inc on Nov 7, 2025 in Weston, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 7, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Weston, FL (United States)
Additional Details
Bioanalytical BA/BE